Gapping up
In reaction to strong earnings/guidance: FB +18.8% (several analysts increasing price targets), INFN +15.6%, UA +11.5%, CRR +11.2%, ININ +10.6%, BX +8.5%, ALXN +8.4%, FLEX +7.1%, (also upgraded to Buy from Hold at Craig Hallum), CNQR +6.6%, NOW +5.9%, HAR +5.5%, CSII +5.4% (light volume), PHM +5%, TMO +3.8%, (light volume), CAH +3.8%, (light volume), V +3.6%,QCOM +3.2%, FTNT +2.8%, ATK +2.8%, LRCX +2.4%, RDS.A +2.4%, QLGC +2.3%, (light volume), ERIC +2.1%, MMM +0.6%.
M&A news: ACCL +28.6% (Accelrys to be acquired by Dassault Systèmes for $12.50/share), GOOG +2.4% (Google confirms Lenovo acquiring Motorola Mobility; closing is not subject to any financing condition or vote of Google's or Lenovo's stockholders).
Select oil/gas related names showing strength: YPF +4.2%, DVN +2.2%, NOG +2.7% (announced 4Q2013 production is expected to average ~ 13,900 barrels of oil equivalent (Boe) per day, up 28% y/y), BP +0.5% ( DoJ says BP to remain banned for US contracts, according to reports), GPOR +2.1% ( announces retirement of CEO James Palm), MPO +2% (provides operation update and preliminary 2014 production and capital guidance; sees Q4 adjusted EBITDA of $115-120 mln).
Social/online media related names higher following FB results: GRPN +7.9%, TWTR +5.5%, QIHU +4.7%, ZNGA +3.2%, LNKD +2.9%, YELP +2.7%, SINA +2.5%, SOCL +2.5%, BIDU +2.1%,
Other news: DEJ +5.7% ( extends Letter of Intent on Colorado Assets), NLST +5.6% ( adds new patents to ULLtraDIMM litigation), GERN +5.1% (announces public offering of common stock; size not disclosed), ONVO +4.2% (continued strength), ORMP +4% (announces successful FDA Phase 2a clinical trial results), ARIA +3.4% (still checking), DNDN +3.2% (reaffirms positive immune effects of PROVENGE (sipuleucel-T) in treatment of advanced prostate cancer; prelim phase II Data for DN24-02 demonstrate positive immune response in HER2+ Urothelial Cancer Patients), TS +2.5% (still checking), MA +2.3% (MasterCard: EU Court has rejected MA's card fee appeal, according to reports), CSIQ +1.2% (has shipped a record of 508 MW of solar photovoltaic modules under its own Canadian Solar brand thus becoming the largest foreign PV module brand in the Japanese market ), FTK +0.8% (higher following positive Barron's mention), DB +0.7% (has suspended NY EM Forex desk head, according to reports), WYNN +0.5% and MGM +0.5% (despite LVS results).
Analyst comments: P +5.7% (positive Goldman comments -- sees upside on potential ad load increase), SQNS +5.3% (upgraded to Outperform at Robert W. Baird; tgt raised to $5 ), JBLU +2.4% (JetBlue upgraded to Buy from Hold at Deutsche Bank), STM +2.3% ( tgt raised 5% at Exane BNP Paribas), ADSK +2.1% ( upgraded to Overweight from Neutral at JPMorgan)
M&A news: ACCL +28.6% (Accelrys to be acquired by Dassault Systèmes for $12.50/share), GOOG +2.4% (Google confirms Lenovo acquiring Motorola Mobility; closing is not subject to any financing condition or vote of Google's or Lenovo's stockholders).
Select oil/gas related names showing strength: YPF +4.2%, DVN +2.2%, NOG +2.7% (announced 4Q2013 production is expected to average ~ 13,900 barrels of oil equivalent (Boe) per day, up 28% y/y), BP +0.5% ( DoJ says BP to remain banned for US contracts, according to reports), GPOR +2.1% ( announces retirement of CEO James Palm), MPO +2% (provides operation update and preliminary 2014 production and capital guidance; sees Q4 adjusted EBITDA of $115-120 mln).
Social/online media related names higher following FB results: GRPN +7.9%, TWTR +5.5%, QIHU +4.7%, ZNGA +3.2%, LNKD +2.9%, YELP +2.7%, SINA +2.5%, SOCL +2.5%, BIDU +2.1%,
Other news: DEJ +5.7% ( extends Letter of Intent on Colorado Assets), NLST +5.6% ( adds new patents to ULLtraDIMM litigation), GERN +5.1% (announces public offering of common stock; size not disclosed), ONVO +4.2% (continued strength), ORMP +4% (announces successful FDA Phase 2a clinical trial results), ARIA +3.4% (still checking), DNDN +3.2% (reaffirms positive immune effects of PROVENGE (sipuleucel-T) in treatment of advanced prostate cancer; prelim phase II Data for DN24-02 demonstrate positive immune response in HER2+ Urothelial Cancer Patients), TS +2.5% (still checking), MA +2.3% (MasterCard: EU Court has rejected MA's card fee appeal, according to reports), CSIQ +1.2% (has shipped a record of 508 MW of solar photovoltaic modules under its own Canadian Solar brand thus becoming the largest foreign PV module brand in the Japanese market ), FTK +0.8% (higher following positive Barron's mention), DB +0.7% (has suspended NY EM Forex desk head, according to reports), WYNN +0.5% and MGM +0.5% (despite LVS results).
Analyst comments: P +5.7% (positive Goldman comments -- sees upside on potential ad load increase), SQNS +5.3% (upgraded to Outperform at Robert W. Baird; tgt raised to $5 ), JBLU +2.4% (JetBlue upgraded to Buy from Hold at Deutsche Bank), STM +2.3% ( tgt raised 5% at Exane BNP Paribas), ADSK +2.1% ( upgraded to Overweight from Neutral at JPMorgan)